CHU AMBROISE PARE
Also known as: Ambroise Paré hospital | AP-HP - Hôpital Ambroise-Paré | C.H.U. AMBROISE PARE AP-HP, Boulogne-Billancourt, France | CMC Ambroise Paré | CMC Ambroise Paré, Neuilly-sur-Seine, France | Department of Anesthesia and Intensive Care - Ambroise Paré Hospital - APHP | Department of Orthopaedics and Traumatology, Ambroise Paré hospital, APHP | Hopital Ambroise Pare | Hospital Ambroise Pare | Hospital Ambroise Pare, Department of Dermatology | Hospital Ambroise Pare Paris | Hospital Ambroise Paré Paris | Infectiology mobile team, Ambroise Paré hospital, APHP | Nadine ATTAL | Orthopaedics, Ambroise Paré hospital, APHP | Orthopedic surgery department, Ambroise Paré hospital, APHP | Orthopédie et traumatologie, Hôpital Ambroise Paré, Boulogne-Billancourt | Pharmacy of Ambroise-Paré hospital, APHP
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2000Last known activity
Jul 10, 2024
Timeline
1920s
- Jun 1, 1923
CHU AMBROISE PARE— Founded
Drugs by trial phase (32 distinct, 31 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (38)
- NCT06274294Lead sponsorPhase 3Jul 10, 2024
- NCT06040840Lead sponsorN/ANov 1, 2023
- NCT05072704Lead sponsorPhase 3Nov 1, 2021
- NCT05046860Overall official - principal investigatorN/ASep 29, 2021
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04607122Lead sponsorPhase 3Dec 28, 2020
- NCT04607122Study chairPhase 3Dec 28, 2020
- NCT04494100Lead sponsorN/ASep 11, 2020
- NCT04433390Lead sponsorPhase 3Jul 1, 2020
- NCT04213781Lead sponsorN/AFeb 1, 2020
- NCT04046744Lead sponsorN/AOct 7, 2019
- NCT03956264Lead sponsorN/AJul 15, 2019
- NCT03834129Lead sponsorPhase 3May 13, 2019
- NCT03773822Lead sponsorPhase 3Apr 21, 2019
- NCT03734159Lead sponsorPhase 4Dec 13, 2018
Details
- Founded
- Mons, BE Jun 1, 1923
- Last known activity
- Jul 10, 2024